|By PR Newswire||
|March 26, 2014 01:09 PM EDT||
LONDON, March 26, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
TechNavio's analysts forecast the Global Gynecological Cancers market to grow at a CAGR of 12.47 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in prevalence of gynecological cancer. The Global Gynecological Cancers market has also been witnessing the emergence of personalized medicines. However, the increase in use of CAM could pose a challenge to the growth of this market.
TechNavio's report, the Global Gynecological Cancers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Gynecological Cancers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are Becton Dickinson and Co., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., and GlaxoSmithKline plc.
Other vendor mentioned in the report is Merck & Co.
Key questions answered in this report:
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Global Ovarian Cancers Market
06.3.1 Market Size and Forecast
06.4 Global Cervical Cancers Market
06.4.1 Market Size and Forecast
06.5 Global Uterine Cancer Market
06.5.1 Market Size and Forecast
06.6 Five Forces Analysis
07. Geographical Segmentation
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors
16. Key Vendor Analysis
16.1 Becton, Dickinson and Co.
16.1.1 Business Overview
16.1.2 Business Segmentation
16.1.3 Key Information
16.1.4 SWOT Analysis
16.2 Bristol Myers Squibb Co.
16.2.1 Business Overview
16.2.2 Key Information
16.2.3 SWOT Analysis
16.3 Eli Lilly and Co.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis
16.4 F. Hoffmann La Roche Ltd.
16.4.1 Business Overview
16.4.2 Business Segmentation
16.4.3 Key Information
16.4.4 SWOT Analysis
16.5 GlaxoSmithKline plc
16.5.1 Business Overview
16.5.2 Business Segmentation
16.5.3 Key Information
16.5.4 SWOT Analysis
17. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Gynecological Cancers Market 2013-2018 (US$ billion)
Exhibit 3: Global Ovarian Cancers Market 2013-2018 (US$ billion)
Exhibit 4: Global Cervical Cancers Market 2013-2018 (US$ billion)
Exhibit 5: Global Uterine Cancer Market 2013-2018 (US$ billion)
Exhibit 6: Global Gynecological Cancers Market by Geographical Segmentation 2013
Exhibit 7: Business Segmentation of Becton, Dickinson and Co.
Exhibit 8: Business Segmentation of F. Hoffmann La Roche Ltd.
Exhibit 9: Business Segmentation of GlaxoSmithKline plc.
Becton Dickinson and Co., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline plc., Merck & Co.
Read the full report:
Global Gynecological Cancers Market 2014-2018
To support developers and operations professionals in their push to implement DevOps principles for their infrastructure environments, ProfitBricks, a provider of cloud infrastructure, is adding support for DevOps tools Ansible and Chef. Ansible is a platform for configuring and managing data center infrastructure that combines multi-node software deployment, ad hoc task execution, and configuration management, and is used by DevOps professionals as they use its playbooks functionality to autom...
Sep. 3, 2015 10:15 PM EDT
SYS-CON Events announced today that IceWarp will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. IceWarp, the leader of cloud and on-premise messaging, delivers secured email, chat, documents, conferencing and collaboration to today's mobile workforce, all in one unified interface
Sep. 3, 2015 10:00 PM EDT Reads: 481
Sep. 3, 2015 10:00 PM EDT Reads: 173
Sep. 3, 2015 09:30 PM EDT Reads: 115
Sep. 3, 2015 08:30 PM EDT Reads: 147
Sep. 3, 2015 08:00 PM EDT Reads: 445
Sep. 3, 2015 07:15 PM EDT Reads: 106
Sep. 3, 2015 05:30 PM EDT Reads: 361
Sep. 3, 2015 05:15 PM EDT Reads: 532
Sep. 3, 2015 05:00 PM EDT Reads: 544
Sep. 3, 2015 04:30 PM EDT Reads: 429
Sep. 3, 2015 04:00 PM EDT Reads: 259
Sep. 3, 2015 03:00 PM EDT Reads: 1,605
Sep. 3, 2015 02:45 PM EDT Reads: 387
Sep. 3, 2015 02:45 PM EDT Reads: 481